The body mass index (BMI) may be associated with an increased incidence and aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the BMI on survival in patients with T1G3 non-muscle-invasive bladder cancer (NMIBC).
Ferro, M., Vartolomei, M.d., Russo, G.i., Cantiello, F., Farhan, A., Terracciano, D., et al. (2019). An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. WORLD JOURNAL OF UROLOGY, 37(3), 507-514 [10.1007/s00345-018-2397-1].
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
Di Stasi S.
;Bove P.;Battaglia M.;Lucarelli G.
2019-01-01
Abstract
The body mass index (BMI) may be associated with an increased incidence and aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the BMI on survival in patients with T1G3 non-muscle-invasive bladder cancer (NMIBC).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
World Journal of Urology 2019_37_507_514.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
1.54 MB
Formato
Adobe PDF
|
1.54 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
